Target intelligence / Profile preview

Solute carrier family 12 member 3 (Sodium-chloride symporter) (NCC)

Target
NCC
Molecular classification
Transporter, Solute carrier family
01

Overview

The Solute carrier family 12 member 3, commonly known as the sodium-chloride symporter (NCC), is a transmembrane protein located primarily in the apical membrane of the distal convoluted tubule (DCT) in the kidney. Its primary biological function is the electroneutral reabsorption of sodium and chloride ions from the tubular fluid back into the renal epithelial cells, accounting for approximately 5-10% of filtered sodium reabsorption (UniProt P55017; NIH/StatPearls). By regulating the amount of salt returned to the bloodstream, NCC plays a critical role in maintaining long-term blood pressure and extracellular fluid volume. Mutations in the SLC12A3 gene that cause a loss of function lead to Gitelman syndrome, characterized by low blood pressure and electrolyte imbalances, while overactivity is associated with hypertension (PubMed PMID: 25568244). NCC is the primary pharmacological target for thiazide and thiazide-like diuretics, which are first-line treatments for essential hypertension and edema. These drugs bind to the chloride-binding site of the transporter, inhibiting its activity and promoting the excretion of salt and water (PubChem; NIH/StatPearls).

Other names
Thiazide-sensitive sodium-chloride cotransporterTSCSLC12A3Na-Cl cotransporterSodium-chloride symporter
02

Mechanism of action

Inhibition of the sodium-chloride symporter in the distal convoluted tubule, which prevents the reabsorption of sodium and chloride ions, leading to increased natriuresis and diuresis.

03

Biological functions

Ion transportSodium reabsorptionChloride reabsorptionBlood pressure regulationElectrolyte homeostasisRenal handling of divalent cations
04

Disease associations

HypertensionGitelman syndromeCardiovascular diseaseEdemaCongestive heart failureNephrolithiasis
05

Safety considerations

HypokalemiaHyponatremiaHypomagnesemiaHypercalcemiaHyperuricemiaGlucose intoleranceOrthostatic hypotension
06

Interacting drugs

Hydrochlorothiazide

6 more in the full profile.

07

Biomarkers

Urinary sodium-to-potassium ratioSerum potassium levelsPlasma renin activityUrinary calcium excretionBlood pressure reduction

Beyond the preview

Go deeper on Solute carrier family 12 member 3 (Sodium-chloride symporter) (NCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 12 member 3 (Sodium-chloride symporter) (NCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call